Clinicopathologic Factors Associated With Occult Lymph Node Metastasis in Patients With Clinically Diagnosed N0 Lung Adenocarcinoma.

[1]  M. Tsuboi,et al.  Mediastinal Nodal Involvement in Patients with Clinical Stage I Non–Small-Cell Lung Cancer: Possibility of Rational Lymph Node Dissection , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[2]  Jin-Hyoung Kang,et al.  Correlation of histological components with tumor invasion in pulmonary adenocarcinoma , 2014, World Journal of Surgical Oncology.

[3]  Yang Zhang,et al.  A Comprehensive Investigation of Molecular Features and Prognosis of Lung Adenocarcinoma with Micropapillary Component , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[4]  L. Chao,et al.  Relevance of EGFR mutation with micropapillary pattern according to the novel IASLC/ATS/ERS lung adenocarcinoma classification and correlation with prognosis in Chinese patients. , 2014, Lung cancer.

[5]  David R. Jones,et al.  The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know. , 2014, Seminars in thoracic and cardiovascular surgery.

[6]  Y. Takeshima,et al.  Prediction for prognosis of resected pT1a-1bN0M0 adenocarcinoma based on tumor size and histological status: relationship of TNM and IASLC/ATS/ERS classifications. , 2014, Lung cancer.

[7]  S. Shiono,et al.  The correlation of the International Association for the Study of Lung Cancer (IASLC)/American Thoracic Society (ATS)/European Respiratory Society (ERS) classification with prognosis and EGFR mutation in lung adenocarcinoma. , 2014, The Annals of thoracic surgery.

[8]  T. Chou,et al.  Predictive value of the international association for the study of lung cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma in tumor recurrence and patient survival. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Wang Li,et al.  Predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma. , 2014, The Annals of thoracic surgery.

[10]  Yanqin Sun,et al.  The role of (18)F-FDG PET/CT for evaluation of metastatic mediastinal lymph nodes in patients with lung squamous-cell carcinoma or adenocarcinoma. , 2014, Lung cancer.

[11]  Akihiko Yoshizawa,et al.  Prognostic Significance of Adenocarcinoma In Situ, Minimally Invasive Adenocarcinoma, and Nonmucinous Lepidic Predominant Invasive Adenocarcinoma of the Lung in Patients With Stage I Disease , 2014, The American journal of surgical pathology.

[12]  D. de Ruysscher,et al.  Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  Q. Tan,et al.  Why Do Pathological Stage IA Lung Adenocarcinomas Vary from Prognosis?: A Clinicopathologic Study of 176 Patients with Pathological Stage IA Lung Adenocarcinoma Based on the IASLC/ATS/ERS Classification , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[14]  Yong Soo Choi,et al.  Prognosis of unexpected and expected pathologic N1 non-small cell lung cancer. , 2013, The Annals of thoracic surgery.

[15]  Prasad S Adusumilli,et al.  Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller. , 2013, Journal of the National Cancer Institute.

[16]  R. Mehran.  The role of surgery in patients with clinical n2 disease. , 2013, Thoracic surgery clinics.

[17]  A. Yoshizawa,et al.  Pulmonary adenocarcinomas with micropapillary component significantly correlate with recurrence, but can be well controlled with EGFR tyrosine kinase inhibitors in the early stages. , 2013, Lung cancer.

[18]  Ying Liu,et al.  Primary tumor PET/CT [18F]FDG uptake is an independent predictive factor for regional lymph node metastasis in patients with non-small cell lung cancer , 2013, Cancer imaging : the official publication of the International Cancer Imaging Society.

[19]  T. Chou,et al.  Stromal invasion and micropapillary pattern in 212 consecutive surgically resected stage I lung adenocarcinomas: histopathological categories for prognosis prediction , 2012, Journal of Clinical Pathology.

[20]  Kenji Suzuki,et al.  Is limited resection appropriate for radiologically "solid" tumors in small lung cancers? , 2012, The Annals of thoracic surgery.

[21]  Jie Gao,et al.  Pulmonary adenocarcinoma with a micropapillary pattern: a clinicopathological, immunophenotypic and molecular analysis , 2011, Histopathology.

[22]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[23]  J. Austin,et al.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011, Journal of Thoracic Oncology.

[24]  J. Ferlay,et al.  Fifty years of cancer incidence: CI5 I–IX , 2010, International journal of cancer.

[25]  Akihiko Yoshizawa,et al.  A Grading System of Lung Adenocarcinomas Based on Histologic Pattern is Predictive of Disease Recurrence in Stage I Tumors , 2010, The American journal of surgical pathology.

[26]  M. Tsuboi,et al.  A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). , 2010, Japanese journal of clinical oncology.

[27]  Y. Maehara,et al.  Clinically predictive factors of pathologic upstaging in patients with peripherally located clinical stage IA non-small cell lung cancer. , 2007, Lung cancer.

[28]  L V Rubinstein,et al.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. , 1995, The Annals of thoracic surgery.

[29]  R. Rintoul,et al.  Stage migration: results of lymph node dissection in the era of modern imaging and invasive staging for lung cancer. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[30]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.